Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 145Liver physiology and pathologyLiver Disease Diagnosis and TreatmentImmune cells in cancer

The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index; 51 of the 69 sources its claims cite were checked for support.

Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2

Open access

Abstract

While macrophage heterogeneity during metabolic dysfunction-associated steatohepatitis (MASH) has been described, the fate of these macrophages during MASH regression is poorly understood. Comparing macrophage heterogeneity during MASH progression vs regression, we identified specific macrophage subpopulations that are critical for MASH/fibrosis resolution. We elucidated the restorative pathways and gene signatures that define regression-associated macrophages and establish the importance of TREM2 + macrophages during MASH regression. Liver-resident Kupffer cells are lost during MASH and are replaced by four distinct monocyte-derived macrophage subpopulations. Trem2 is expressed in two macrophage subpopulations: i) monocyte-derived macrophages occupying the Kupffer cell niche (MoKC) and ii) lipid-associated macrophages (LAM). In regression livers, no new transcriptionally distinct macrophage subpopulation emerged. However, the relative macrophage composition changed during regression compared to MASH. While MoKC was the major macrophage subpopulation during MASH, they decreased during regression. LAM was the dominant macrophage subtype during MASH regression and maintained Trem2 expression. Both MoKC and LAM were enriched in disease-resolving pathways. Absence of TREM2 restricted the emergence of LAMs and formation of hepatic crown-like structures. TREM2 + macrophages are functionally important not only for restricting MASH-fibrosis progression but also for effective regression of inflammation and fibrosis. TREM2 + macrophages are superior collagen degraders. Lack of TREM2 + macrophages also prevented elimination of hepatic steatosis and inactivation of HSC during regression, indicating their significance in metabolic coordination with other cell types in the liver. TREM2 imparts this protective effect through multifactorial mechanisms, including improved phagocytosis, lipid handling, and collagen degradation.

Overview

CoChat Summary

## TL;DR

Using two mouse models of MASH, the paper shows that TREM2+ lipid-associated macrophages (LAMs) are the main restorative macrophage population during regression and are needed for fibrosis resolution. Loss of TREM2 impairs collagen resorption, steatosis clearance, and hepatic stellate cell inactivation.

## Key findings

  • In Foz/Foz mice, switching from Western diet to chow for regression improved MASH within 4 weeks and continued through 8 weeks, but Foz::Trem2−/− mice had markedly impaired recovery: they failed to eliminate hepatic steatosis and had significantly worse fibrosis resolution.
  • Fibrosis resolution was quantified as 70% at 8 weeks in Foz/Foz mice versus 30% at 8 weeks in Foz::Trem2−/− mice; the linear regression slopes were −0.087 vs −0.039, respectively.
  • scRNAseq of 18 immune cell clusters identified 4 monocyte-derived macrophage populations emerging during MASH; during regression, LAMs (cluster 2) remained constant and became the major macrophage subpopulation, while MoKC shrank.
  • TREM2+ macrophages were enriched for phagocytosis, anti-fibrosis, ECM degradation, and lipid/lipoprotein handling, whereas TREM2-low macrophages were enriched for inflammation, cytokine signaling, and cell death.
  • Absence of TREM2 reduced GPNMB+ LAMs and hCLS in both MASH and regression, increased inflammatory macrophages, and impaired collagen degradation; in BMDMs, Trem2−/− cells were less efficient at collagen degradation than WT.
  • In the second MASH model (WD + 30% fructose in drinking water), Trem2−/− mice developed more severe MASH/fibrosis, and about 60% progressed spontaneously to HCC with an average of 5 tumors/liver of average diameter 2.5 mm.

## Methods

  • Two preclinical mouse models were used: Foz/Foz mice and Trem2−/− mice on a C57BL/6J background, plus Foz::Trem2−/− crosses; mice were fed Western diet or WD + 30% fructose to induce MASH, then some were switched to chow for regression.
  • Regression in the Foz model was assessed at 4 and 8 weeks after WD→chow switch; a separate cohort stayed on WD for 20 weeks as a disease-control group.
  • The main analyses included scRNAseq of immune cells from healthy, MASH, and regression livers; flow cytometry, immunohistochemistry, Luminex cytokine/chemokine profiling, gene expression analysis, and collagenase/collagen degradation assays. Group comparisons used ANOVA and Student’s t test.

## Limitations

  • The paper states that the role of hepatic LAM/hCLS in MASH “remains unresolved” and that the mechanisms by which TREM2 modulates HSC inactivation and hepatic lipid metabolism during regression “need further investigation.”
  • The paper notes that the myeloid population may need “longer time to return to homeostasis,” implying that the 8-week regression window may be too short to capture full recovery.
  • The text makes evident that much of the mechanistic work is based on mouse models rather than direct human intervention studies (text-evident).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.2405746121

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. TREM2 in MASH. (A) Volcano plot of liver RNAseq demonstrating up-regulated (orange) and down-regulated (Green) genes common to mice and human MASH vs. healthy obese (see SI Appendix for methods). (B and C) Formalin-fixed paraffin-embedded (FFPE) human (B) and Alms1−/− (Foz/Foz) mice (C) liver sections were costained with anti-type 1 collagen (red) and TREM2 (green) antibodies (Scale bar, 30 µm for human and 10 µm for mouse sections) with corresponding quantifications. (D) qRT-PCR analysis of Trem2 in WT and Foz/Foz livers. (E) Experimental design. Six- to eight-week-old Foz/Foz and Foz::Trem2−/− (T2−/− Foz) mice were placed on WD for 8 to 24 wk. (F) Representative hematoxylin and eosin (H&E) and Sirius red (SR)–stained mouse liver sections and corresponding ImageJ quantifications. (Scale bar, 200 µm.) (G–J) Total liver RNA was subjected to qRT-PCR for (G) Col1α1, (H) Timp1, (I) Mcp1, and (J) Cd11b, gene expression. (K) Plasma lipopolysaccharide (LPS) and lipopolysaccharide-binding protein (LBP) levels were determined using ELISA. Data are expressed as mean ± SEM; one-way ANOVA and T-test; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Fig. 1. TREM2 in MASH. (A) Volcano plot of liver RNAseq demonstrating up-regulated (orange) and down-regulated (Green) genes common to mice and human MASH vs. healthy obese (see SI Appendix for methods). (B and C) Formalin-fixed paraffin-embedded (FFPE) human (B) and Alms1−/− (Foz/Foz) mice (C) liver sections were costained with anti-type 1 collagen (red) and TREM2 (green) antibodies (Scale bar, 30 µm for human and 10 µm for mouse sections) with corresponding quantifications. (D) qRT-PCR analysis of Trem2 in WT and Foz/Foz livers. (E) Experimental design. Six- to eight-week-old Foz/Foz and Foz::Trem2−/− (T2−/− Foz) mice were placed on WD for 8 to 24 wk. (F) Representative hematoxylin and eosin (H&E) and Sirius red (SR)–stained mouse liver sections and corresponding ImageJ quantifications. (Scale bar, 200 µm.) (G–J) Total liver RNA was subjected to qRT-PCR for (G) Col1α1, (H) Timp1, (I) Mcp1, and (J) Cd11b, gene expression. (K) Plasma lipopolysaccharide (LPS) and lipopolysaccharide-binding protein (LBP) levels were determined using ELISA. Data are expressed as mean ± SEM; one-way ANOVA and T-test; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.CC BY · PubMed Central
Fig. 2. Absence of TREM2 prevents effective MASH and fibrosis resolution. (A) Experimental design: 6- to 8-wk-old Foz/Foz and Foz::Trem2−/− were fed WD for 12 wk to induce MASH/fibrosis. One cohort of mice were then switched to a chow diet for an additional 4 to 8 wk to model MASH regression. Another cohort continued WD as age-matched controls (MASH progression 20 wk). Three distinct time-points were analyzed: 1) MASH 12 wk (MASH-fibrosis immediately before regression), 2) MASH progression 20 wk (MASH-fibrosis in age-matched controls that continued WD), 3) MASH regression (4 and 8 wk regression). (B and C) Representative H&E (B) and SR-stained (C) mouse liver sections (Scale bar, 200 µm) and (D) ImageJ quantifications. (E) Linear regression analysis of SR quantification in Foz/Foz and Foz::Trem2−/− mice after 4 and 8 wk regression normalized to their respective 12 wk MASH SR scores. A greater negative slope in the Foz/Foz group indicates an increased rate of SR-reduction in these mice. (F) The extent of fibrosis resolution during MASH regression was quantified by normalizing SR-positive areas of Foz/Foz and Foz::Trem2−/− mice undergoing regression with the corresponding SR-positive areas at 12-wk MASH (refer to Fig. 1F). This was done to normalize for the higher SR scores of Foz::Trem2−/− + WD mice compared to Foz+WD mice at 12 wk, the time when the mice were put on regression. (G) Total liver RNA was analyzed by qRT-PCR for the expression of indicated inflammatory genes. (H) Liver lysates from regression and age-matched control mice were subjected to immunoblot analysis with the indicated antibodies. (I) Total liver RNA was analyzed by qRT-PCR for the expression of indicated genes. Data are expressed as mean ± SEM; one-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Fig. 2. Absence of TREM2 prevents effective MASH and fibrosis resolution. (A) Experimental design: 6- to 8-wk-old Foz/Foz and Foz::Trem2−/− were fed WD for 12 wk to induce MASH/fibrosis. One cohort of mice were then switched to a chow diet for an additional 4 to 8 wk to model MASH regression. Another cohort continued WD as age-matched controls (MASH progression 20 wk). Three distinct time-points were analyzed: 1) MASH 12 wk (MASH-fibrosis immediately before regression), 2) MASH progression 20 wk (MASH-fibrosis in age-matched controls that continued WD), 3) MASH regression (4 and 8 wk regression). (B and C) Representative H&E (B) and SR-stained (C) mouse liver sections (Scale bar, 200 µm) and (D) ImageJ quantifications. (E) Linear regression analysis of SR quantification in Foz/Foz and Foz::Trem2−/− mice after 4 and 8 wk regression normalized to their respective 12 wk MASH SR scores. A greater negative slope in the Foz/Foz group indicates an increased rate of SR-reduction in these mice. (F) The extent of fibrosis resolution during MASH regression was quantified by normalizing SR-positive areas of Foz/Foz and Foz::Trem2−/− mice undergoing regression with the corresponding SR-positive areas at 12-wk MASH (refer to Fig. 1F). This was done to normalize for the higher SR scores of Foz::Trem2−/− + WD mice compared to Foz+WD mice at 12 wk, the time when the mice were put on regression. (G) Total liver RNA was analyzed by qRT-PCR for the expression of indicated inflammatory genes. (H) Liver lysates from regression and age-matched control mice were subjected to immunoblot analysis with the indicated antibodies. (I) Total liver RNA was analyzed by qRT-PCR for the expression of indicated genes. Data are expressed as mean ± SEM; one-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.CC BY · PubMed Central
Fig. 3. Macrophage heterogeneity during MASH progression and regression. (A–F) Total nonparenchymal cells (NPC) isolated from healthy (Foz + WD 0 wk), MASH (Foz + WD 12 wk), and MASH-regression (Foz + WD 12 wk + Chow 8 wk) mice were subjected to scRNAseq. This analysis focuses on cells of macrophage and monocyte origin. Other NPCs, such as T-cells, B-cells, and dendritic cells (listed in SI Appendix, Fig. S3A), were excluded from this analysis. (A) UMAPs highlighting Monocyte-macrophage clusters, including cells from healthy, MASH, and regression. Individual UMAPs from each condition are shown in the Left panel and the merged UMAP on the Right. (B) Cluster composition plot showing the relative proportion of cells from healthy, MASH, and regression across all the clusters. (C) Heatmap showing relative average expression of cell-type marker genes (Y axis) with their cluster identity (X axis) for monocyte-macrophage subclusters. (D and E) Cluster composition plot showing the relative makeup (D), and cell counts (E), of each cluster in healthy control (Foz + WD 0 wk) and during MASH (Foz + WD 12 wk) and regression. (F) Violin plot showing Trem2 expression in the MoKC and LAM during MASH progression and regression.
Fig. 3. Macrophage heterogeneity during MASH progression and regression. (A–F) Total nonparenchymal cells (NPC) isolated from healthy (Foz + WD 0 wk), MASH (Foz + WD 12 wk), and MASH-regression (Foz + WD 12 wk + Chow 8 wk) mice were subjected to scRNAseq. This analysis focuses on cells of macrophage and monocyte origin. Other NPCs, such as T-cells, B-cells, and dendritic cells (listed in SI Appendix, Fig. S3A), were excluded from this analysis. (A) UMAPs highlighting Monocyte-macrophage clusters, including cells from healthy, MASH, and regression. Individual UMAPs from each condition are shown in the Left panel and the merged UMAP on the Right. (B) Cluster composition plot showing the relative proportion of cells from healthy, MASH, and regression across all the clusters. (C) Heatmap showing relative average expression of cell-type marker genes (Y axis) with their cluster identity (X axis) for monocyte-macrophage subclusters. (D and E) Cluster composition plot showing the relative makeup (D), and cell counts (E), of each cluster in healthy control (Foz + WD 0 wk) and during MASH (Foz + WD 12 wk) and regression. (F) Violin plot showing Trem2 expression in the MoKC and LAM during MASH progression and regression.CC BY · PubMed Central
Fig. 4. Pathways affected by TREM2 in MASH and regression-associated macrophages. (A) A cartoon summarizing the meta-pathways (red/blue circles) and the corresponding GSEA pathways (boxes) which are positively (red) or negatively (blue) correlated with Trem2 expression in macrophages during MASH progression (see SI Appendix for methods). (B) Experimental design. Conditioned media (CM) from liver macrophages isolated from 24 wk FrWD-fed WT and Trem2−/− mice were added to HSC isolated from chow-fed WT mice. (C) Total RNA isolated from the HSC 24 h post CM incubation was subjected to qRT-PCR to identify gene expression changes in fibrogenic markers. Gene expression is normalized to HPRT as well as to the number of live macrophages that produced the corresponding CM. (D) Heatmap showing relative mean expression of the genes belonging to Trem2 correlated pathways, of clusters 1, 2, 5, and 15 during MASH progression (MASH) and MASH regression (Reg) (see SI Appendix for methods). Data are expressed as mean ± SEM; T-test; *P < 0.05, **P < 0.01.
Fig. 4. Pathways affected by TREM2 in MASH and regression-associated macrophages. (A) A cartoon summarizing the meta-pathways (red/blue circles) and the corresponding GSEA pathways (boxes) which are positively (red) or negatively (blue) correlated with Trem2 expression in macrophages during MASH progression (see SI Appendix for methods). (B) Experimental design. Conditioned media (CM) from liver macrophages isolated from 24 wk FrWD-fed WT and Trem2−/− mice were added to HSC isolated from chow-fed WT mice. (C) Total RNA isolated from the HSC 24 h post CM incubation was subjected to qRT-PCR to identify gene expression changes in fibrogenic markers. Gene expression is normalized to HPRT as well as to the number of live macrophages that produced the corresponding CM. (D) Heatmap showing relative mean expression of the genes belonging to Trem2 correlated pathways, of clusters 1, 2, 5, and 15 during MASH progression (MASH) and MASH regression (Reg) (see SI Appendix for methods). Data are expressed as mean ± SEM; T-test; *P < 0.05, **P < 0.01.CC BY · PubMed Central
Fig. 5. Absence of TREM2 suppresses emergence of LAMs during MASH progression and regression. (A–C) MASH progression. (A) Representative images of GPNMB (red) (DAPI = blue) (Scale bar, 200 µm) stained FFPE liver sections from Foz/Foz and Foz::Trem −/− mice undergoing MASH progression (12 wk). Corresponding quantification of GPNMB+ hCLS in each randomly selected high-power field (hpf) on the Right. (B) qRT-PCR analysis of total liver RNA for Gpnmb expression. (C) FFPE sections from these mice were also stained with anti-Cd11b antibody. (Scale bar, 200 µm.) Representative images are shown with corresponding quantifications. (D–F) MASH regression. (D) Representative images of GPNMB (red) (DAPI = blue) (Scale bar, 200 µm) stained FFPE liver sections and quantification. (E) qRT-PCR analysis of total liver RNA for Gpnmb expression. (F) Representative Cd11b stained images of FFPE liver sections with quantification. (G–I) Flow cytometry of liver NPC isolated from Foz/Foz and Foz::Trem2−/− mice undergoing MASH progression and regression for LAM (CD9+), MoKC (Clec4f+), and Ly6Chi macrophage subpopulations. Bar diagrams show the fold change in the proportion of (G) F4/80+CD9+, (H) F4/80+Clec4f+, and (I) Cd11b+Ly6c+ cells in the indicated groups compared to the Foz + WD 12 wk MASH group. Data are expressed as mean ± SEM; one-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Fig. 5. Absence of TREM2 suppresses emergence of LAMs during MASH progression and regression. (A–C) MASH progression. (A) Representative images of GPNMB (red) (DAPI = blue) (Scale bar, 200 µm) stained FFPE liver sections from Foz/Foz and Foz::Trem −/− mice undergoing MASH progression (12 wk). Corresponding quantification of GPNMB+ hCLS in each randomly selected high-power field (hpf) on the Right. (B) qRT-PCR analysis of total liver RNA for Gpnmb expression. (C) FFPE sections from these mice were also stained with anti-Cd11b antibody. (Scale bar, 200 µm.) Representative images are shown with corresponding quantifications. (D–F) MASH regression. (D) Representative images of GPNMB (red) (DAPI = blue) (Scale bar, 200 µm) stained FFPE liver sections and quantification. (E) qRT-PCR analysis of total liver RNA for Gpnmb expression. (F) Representative Cd11b stained images of FFPE liver sections with quantification. (G–I) Flow cytometry of liver NPC isolated from Foz/Foz and Foz::Trem2−/− mice undergoing MASH progression and regression for LAM (CD9+), MoKC (Clec4f+), and Ly6Chi macrophage subpopulations. Bar diagrams show the fold change in the proportion of (G) F4/80+CD9+, (H) F4/80+Clec4f+, and (I) Cd11b+Ly6c+ cells in the indicated groups compared to the Foz + WD 12 wk MASH group. Data are expressed as mean ± SEM; one-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.CC BY · PubMed Central
Fig. 6. TREM2+ macrophages have high collagenolytic activities. (A) scRNAseq data from MASH and regression macrophage subpopulations (clusters 1, 2, 5, and 15) was analyzed as described in Figs. 3 and 4. Heat map showing relative expression of indicated genes belonging to reparative pathways (lipid handling, phagocytosis, and anti-fibrotic), among the various macrophage subpopulations during MASH and regression (Reg). These genes were selected based on a previous report (20), for their association with restorative macrophage phenotype during regression of CCl4-induced liver fibrosis. Only statistically significant genes (P < 0.05) were plotted. (B–D) Biochemical analysis of collagen degradation. (B) The fluorescent signal in intact fluorescein-labeled DQTM type-1 collagen remains quenched. Upon substrate hydrolysis by collagenases, the fluorescence signal increases which is used to measure enzymatic activity. (C) WT and Trem2−/− BMDMs were subjected to DQTM collagen assay. The measured fluorescence intensity was normalized to the cell count and represented as fold change compared to WT BMDM. (D) Foz/Foz and Foz::Trem2−/− mice were subjected to MASH (12 wk WD) and regression (4 wk). Macrophages isolated from the livers of indicated groups and were subjected to the DQTM collagen assay. The fluorescence intensity was normalized to the protein content of the cell lysates and plotted. (E–H) WT and Trem2−/− mice were administered CCl4 for 6 wk, followed by 10 d recovery. (E) Experimental design. (F) Total liver RNA was subjected to qRT-PCR for Col1α1 and Timp1 genes, normalized to Hprt, and plotted as fold change compared to the WT + CCl4 group. (G) Representative SR-stained mouse liver sections (Scale bar, 200 µm) and ImageJ quantifications. (H) The extent of fibrosis resolution during regression of CCl4-induced liver fibrosis was calculated by normalizing SR-positive areas of WT and Trem2−/− mice undergoing regression with the corresponding SR-positive areas at 6-wk CCl4 dosing. Data are expressed as mean ± SEM; one-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Fig. 6. TREM2+ macrophages have high collagenolytic activities. (A) scRNAseq data from MASH and regression macrophage subpopulations (clusters 1, 2, 5, and 15) was analyzed as described in Figs. 3 and 4. Heat map showing relative expression of indicated genes belonging to reparative pathways (lipid handling, phagocytosis, and anti-fibrotic), among the various macrophage subpopulations during MASH and regression (Reg). These genes were selected based on a previous report (20), for their association with restorative macrophage phenotype during regression of CCl4-induced liver fibrosis. Only statistically significant genes (P < 0.05) were plotted. (B–D) Biochemical analysis of collagen degradation. (B) The fluorescent signal in intact fluorescein-labeled DQTM type-1 collagen remains quenched. Upon substrate hydrolysis by collagenases, the fluorescence signal increases which is used to measure enzymatic activity. (C) WT and Trem2−/− BMDMs were subjected to DQTM collagen assay. The measured fluorescence intensity was normalized to the cell count and represented as fold change compared to WT BMDM. (D) Foz/Foz and Foz::Trem2−/− mice were subjected to MASH (12 wk WD) and regression (4 wk). Macrophages isolated from the livers of indicated groups and were subjected to the DQTM collagen assay. The fluorescence intensity was normalized to the protein content of the cell lysates and plotted. (E–H) WT and Trem2−/− mice were administered CCl4 for 6 wk, followed by 10 d recovery. (E) Experimental design. (F) Total liver RNA was subjected to qRT-PCR for Col1α1 and Timp1 genes, normalized to Hprt, and plotted as fold change compared to the WT + CCl4 group. (G) Representative SR-stained mouse liver sections (Scale bar, 200 µm) and ImageJ quantifications. (H) The extent of fibrosis resolution during regression of CCl4-induced liver fibrosis was calculated by normalizing SR-positive areas of WT and Trem2−/− mice undergoing regression with the corresponding SR-positive areas at 6-wk CCl4 dosing. Data are expressed as mean ± SEM; one-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.CC BY · PubMed Central

Verification

Claims the paper makes

39 Valid · 2 Not valid · 6 Not checked · 132 Own results and interpretations

111 more claims · 12 with their cited sources checked

Create a free account to see all 179 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 44
  • Probably not a substantial claim. 23

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. S. Ganguly Lipid Associated Macrophages’ Promotion of Fibrosis Resolution during MASH regression requires TREM2. GEO. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261829. Deposited 18 March 2024.

Cited by

See all 145

Metadata

Authors
Ganguly, S., Rosenthal, S. B., Ishizuka, K., Troutman, T. D., Rohm, T. V., Khader, N., Aleman-Muench, G., Sano, Y., Archilei, S., Soroosh, P., Olefsky, J. M., Feldstein, A. E., Kisseleva, T., Loomba, R., Glass, C. K., Brenner, D. A., & Dhar, D.
Affiliations
  • Sanford Burnham Prebys Medical Discovery Institute (US)
  • University of California San Diego (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • Cardiovascular and Metabolism discovery, Immunometabolism, Janssen Research &amp; Development, La Jolla, CA 92121
Corresponding author
  • Glass, Christopher K.
  • Brenner, David A.
  • Dhar, Debanjan
Venue
Proceedings of the National Academy of Sciences
Published
2024-08-22
Volume
121
Issue
35
Pages
e2405746121-e2405746121
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4401753386
Cited by
145
References
44
Citations by year
2026: 80 · 2025: 62 · 2024: 3
FWCI
37.48
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK137061 R01DK133930DK091183)
  • HHS | NIH | National Heart, Lung, and Blood Institute (HL147835)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
TREM2, nonalcoholic steatohepatitis, lipid-associated macrophages, Kupffer cells, monocyte-derived macrophages, macrophage heterogeneity, crown-like structures, collagen degradation, hepatic steatosis, phagocytosis, lipid handling, liver inflammation
MeSH terms
Animals, Fatty Liver, Kupffer Cells, Lipids, Liver, Liver Cirrhosis, Macrophages, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Receptors, Immunologic, Mice, Knockout, Lipid Metabolism, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2. https://app.cochat.ai/papers/10.1073/pnas.2405746121
The paper
Ganguly, S., Rosenthal, S. B., Ishizuka, K., Troutman, T. D., Rohm, T. V., Khader, N., Aleman-Muench, G., Sano, Y., Archilei, S., Soroosh, P., Olefsky, J. M., Feldstein, A. E., Kisseleva, T., Loomba, R., Glass, C. K., Brenner, D. A., & Dhar, D. (2024). Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2405746121

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.